Consensus Hansoh Pharmaceutical Group Company Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:35 2024-05-22 am EDT			5-day change	1st Jan Change
17.2 ^HKD	-2.93%		-4.44%	+9.14%

Apr. 29	Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024	CI
Apr. 03	Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	MT

9da98070.5_Og7nBYDWqDTYHzpJ6MFhTxZ4DH08OSC58jMQlrvnQ.gZeV2D4MSA3JIsOUydHCJ12QF-qtg7f0Ss9qVzobhkWAy9q5Pxp5D-4PzA~17db78d365bae062d29c178d402e301b

Nomura Downgrades Hansoh Pharmaceutical to Neutral From Buy, Adjusts Price Target to HK$15.03 From HK$13.01	Mar. 14	MT
Rising Interest Rates Blunt Asian Stock Markets	23-09-26	MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$13.01 From HK$19.49, Keeps at Buy	23-09-01	MT
Fitch US Debt Downgrade Undercuts Asian Stock Markets	23-08-02	MT
China Economic Prospects, Exchange Rates Churn Asian Stock Markets	23-07-24	MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.49 From HK$20.31, Keeps at Buy	23-03-10	MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.31 From HK$20.88, Keeps at Buy	22-08-29	MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.88 From HK$21.11, Keeps at Buy	22-03-30	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.43 CNY

Average target price

17.86 CNY

Spread / Average Target

+8.71%

High Price Target

25.83 CNY

Spread / Highest target

+57.26%

Low Price Target

13.87 CNY

Spread / Lowest Target

-15.58%

Nomura

Trading Rating

Investor Rating

ESG Refinitiv

B+